TRIFARMA SpA is an international independent Group with the Mission to develop, manufacture, supply worldwide high quality APIs to global pharmaceutical industry. Trifarma sells 50% of its production to USA, 26% EU, ROW 24%.Trifarma has two manufacturing sites in Italy, one in India, all of them strictly abiding to same Corporate QA protocols, adhering to ICH guidelines, USA FDA and routinely audited by Italian Ministry of Health and international clients.